Related Experiment Video
Updated: Nov 18, 2025

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
Published on: August 15, 2022
COVID-19 Convalescent Plasma: from donation to treatment - A Systematic Review & Single Center Experience
Michela M Fabricius1, Dima Dandachi2
1Medical Student, University of Missouri-Columbia, Columbia, Missouri.
Insights
Convalescent plasma, an established therapy, was investigated for treating coronavirus disease 2019 (COVID-19). This study reviews existing research and details establishing a plasma donation program for COVID-19 patients.
Area of Science:
- Immunology
- Infectious Diseases
- Hematology
Background:
- The coronavirus disease 2019 (COVID-19) pandemic necessitated exploring novel and repurposed therapeutic strategies.
- Convalescent plasma, derived from recovered patients, has a history of use in treating viral infections.
- The efficacy and implementation of convalescent plasma for COVID-19 required thorough investigation.
Purpose of the Study:
- To systematically review current research on convalescent plasma as a treatment for COVID-19.
- To describe the practical experience of creating and managing a single-center convalescent plasma donation program.
Main Methods:
- A systematic literature review was conducted to synthesize existing studies on convalescent plasma for COVID-19.
- The establishment of a convalescent plasma donation program was detailed, outlining operational aspects.
Main Results:
- The systematic review summarized the available evidence regarding convalescent plasma therapy in COVID-19 patients.
- The description of the donation program provided insights into logistical and operational considerations.
Conclusions:
- Convalescent plasma emerged as a potential therapeutic option during the COVID-19 pandemic.
- The establishment of donation programs is crucial for facilitating the use of convalescent plasma in clinical settings.
Abstract:
Convalescent plasma is an old treatment for a new disease. The coronavirus disease 2019 (COVID-19) pandemic caused the analysis of convalescent plasma to reemerge as a possible treatment. First, a systematic review summarizes the available research examining the use of convalescent plasma for the treatment of patients with COVID-19. Second, we describe our experience in establishing a single-center convalescent plasma donation program.

